Mbadu Mbuzi Eminence, Weber Irène Paola, Humair Jean-Paul, Gillabert Cédric, Bastid Caroline
Service de médecine de premier recours, Hôpitaux universitaires de Genève, 1211 Genève 14.
Centre médical de Lancy, Route de Chancy 59C, 1213 Petit-Lancy.
Rev Med Suisse. 2022 Sep 28;18(797):1784-1787. doi: 10.53738/REVMED.2022.18.797.1784.
Dyspepsia is defined as epigastric pain that lasts at least one month and may be associated with a range of other upper gastrointestinal symptoms. Approximately 2/3 of outpatients with dyspepsia have a functional dyspepsia. The clinical assessment of dyspepsia is based on age of patients as well and the search for severity criteria. The endoscopy in cases of new-onset dyspepsia is recommended from an age of 55-60 and the presence of at least 1 severity criteria. A non-invasive test for Helicobacter pylori (HP) should be performed in all patients and followed by HP eradication when HP test is positive. The first-choice treatment of functional dyspepsia is a proton pump inhibitor (PPI) at maximal dose for 8 weeks. A therapeutic trial with a prokinetic or a central neuromodulator are alternatives to consider in case of failure of PPI treatment.
Rev Med Suisse. 2022-9-28
Acta Clin Croat. 2021-12
Rev Med Suisse. 2023-8-30
Med Clin North Am. 2020-11-7
Curr Gastroenterol Rep. 2009-8
Best Pract Res Clin Gastroenterol. 2019-7-22